focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life Private Equity Trst

24 Feb 2022 07:00

RNS Number : 6095C
Standard Life Private Eqty Trst PLC
24 February 2022
 

 

London, UK, 24 February 2022

 

Edison issues review on Standard Life Private Equity Trust (SLPE)

Standard Life Private Equity Trust (SLPET) delivered a strong NAV total return (TR) of 37.9% in FY21 to end-September 2021, ahead of the FTSE All-Share index at 27.9%. It benefitted from particularly high deal activity in private markets, benign public equity markets and strong interest in quality private assets in 2021. SLPET continued to pursue its broadened investment mandate, with co-investments making up 11% of NAV at end-FY21 (c 16% accounting for deals post reporting date) and its exposure to secondary investments standing at 12% of NAV at end-FY21. With an overcommitment ratio of 34.5% (at the lower end of its targeted 30-75% range), it is likely to sustain a high level of investment activity into FY22.

 

While competition for quality private assets remains high, we note that SLPET invests primarily in PE mid-market funds, typically of €1.0-5.0bn in size and, increasingly, in lower mid-market players of €150m to €1.0bn in size. In recent years, these funds have overall accumulated less capital that needs to be deployed than PE 'megafunds' of high single-digit billion euros or more in size, which should allow the mid-market funds to be more selective in their investments and time their capital deployment better. At the same time, mid-market funds should have a broader choice of exit routes, as they are less dependent on exits through IPOs and have a wider group of potential corporate and PE buyers (including megafunds).

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPURUPUPPGAW
Date   Source Headline
8th Oct 20185:07 pmRNSDirector/PDMR Shareholding
2nd Oct 20181:04 pmRNSQuarterly Disclosure
1st Oct 20187:00 amRNSEstimated Net Asset Value at 31 August 2018
1st Oct 20187:00 amRNSQuarterly Trading Statement
7th Sep 20187:00 amRNSDividend Declaration
30th Aug 20182:24 pmRNSDirector/PDMR Shareholding
28th Aug 20187:00 amRNSChange of Auditor
14th Aug 20187:00 amRNSEstimated Net Asset Value at 31 July 2018
8th Aug 20189:14 amRNSDirector/PDMR Shareholding
3rd Aug 20183:33 pmRNSDirector/PDMR Shareholding
17th Jul 201812:17 pmRNSUpdate research from QuotedData
13th Jul 20183:22 pmRNSEdison reviews Standard Life Private Equity Trust
13th Jul 20187:00 amRNSEstimated Net Asset Value at 30 June 2018
11th Jul 20185:32 pmRNSHolding(s) in Company
5th Jul 201811:55 amRNSDirector/PDMR Shareholding
3rd Jul 201812:43 pmRNSQuarterly Disclosure
18th Jun 20187:02 amRNSEstimated Net Asset Value at 31 May 2018
18th Jun 20187:01 amRNSDividend Declaration
18th Jun 20187:00 amRNSHalf-year Report
15th Jun 201811:50 amRNSDirectorate Change
15th May 20187:00 amRNSEstimated Net Asset Value at 30 April 2018
14th May 20183:48 pmRNSDirector/PDMR Shareholding
8th May 201812:06 pmRNSDirector/PDMR Shareholding
8th May 201812:02 pmRNSDirector/PDMR Shareholding
1st May 201812:54 pmRNSDirector/PDMR Shareholding
18th Apr 20183:24 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSEstimated Net Asset Value at 31 March 2018
4th Apr 20182:09 pmRNSQuarterly Disclosure
26th Mar 20187:00 amRNSEstimated Net Asset Value at 28 February 2018
26th Mar 20187:00 amRNSQuarterly Trading Statement
21st Mar 20187:00 amRNSDividend Declaration
16th Mar 20189:46 amRNSHolding(s) in Company
13th Mar 201810:53 amRNSHolding(s) in Company
8th Mar 201811:00 amRNSKepler Trust Intelligence Research
27th Feb 20185:22 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSEstimated Net Asset Value at 31 January 2018
9th Feb 20183:45 pmRNSDirector/PDMR Shareholding
9th Feb 20183:44 pmRNSDirector/PDMR Shareholding
7th Feb 201811:38 amRNSEdison review: Standard Life Private Equity Trust
2nd Feb 201811:29 amRNSDirector/PDMR Shareholding
31st Jan 20183:17 pmRNSDirector/PDMR Shareholding
25th Jan 20182:48 pmRNSResult of AGM
15th Jan 20187:00 amRNSEstimated Net Asset Value at 31 December 2017
3rd Jan 20182:28 pmRNSQuarterly Disclosure
3rd Jan 201810:52 amRNSDirector/PDMR Shareholding
14th Dec 20177:00 amRNSEstimated Net Asset Value at 30 November 2017
13th Dec 20173:41 pmRNSDirector/PDMR Shareholding
13th Dec 201711:26 amRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDividend Declaration
8th Dec 201711:58 amRNSUpdate research from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.